Washington University Sleep Center, St. Louis, Missouri.
Carolinas Healthcare Medical Group Sleep Services, Charlotte, North Carolina.
J Clin Sleep Med. 2018 Jul 15;14(7):1245-1247. doi: 10.5664/jcsm.7234.
The diagnostic criteria for obstructive sleep apnea (OSA) in adults, as defined in the International Classification of Sleep Disorders, Third Edition, requires an increased frequency of obstructive respiratory events demonstrated by in-laboratory, attended polysomnography (PSG) or a home sleep apnea test (HSAT). However, there are currently two hypopnea scoring criteria in The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications (AASM Scoring Manual). This dichotomy results in differences among laboratory reports, patient treatments and payer policies. Confusion occurs regarding recognizing and scoring "arousal-based respiratory events" during OSA testing. "Arousal-based scoring" recognizes hypopneas associated with electroencephalography-based arousals, with or without significant oxygen desaturation, when calculating an apnea-hypopnea index (AHI), or it includes respiratory effort-related arousals (RERAs), in addition to hypopneas and apneas, when calculating a respiratory disturbance index (RDI). Respiratory events associated with arousals, even without oxygen desaturation, cause significant, and potentially dangerous, sleep apnea symptoms. During PSG, arousal-based respiratory scoring should be performed in the clinical evaluation of patients with suspected OSA, especially in those patients with symptoms of excessive daytime sleepiness, fatigue, insomnia, or other neurocognitive symptoms. Therefore, it is the position of the AASM that the AASM Scoring Manual scoring criteria for hypopneas, which includes diminished airflow accompanied by either an arousal or ≥ 3% oxygen desaturation, should be used to calculate the AHI. If the AASM Scoring Manual criteria for scoring hypopneas, which includes only diminished airflow plus ≥ 4% oxygen desaturation (and does not allow for arousal-based scoring alone), must be utilized due to payer policy requirements, then hypopneas as defined by the AASM Scoring Manual criteria should also be scored. Alternatively, the AASM Scoring Manual includes an option to report an RDI which also provides an assessment of the sleep-disordered breathing that results in arousal from sleep. Furthermore, given the inability of most HSAT devices to capture arousals, a PSG should be performed in any patient with an increased risk for OSA whose HSAT is negative. If the PSG yields an AHI of 5 or more events/h, or if the RDI is greater than or equal to 5 events/h, then treatment of symptomatic patients is recommended to improve quality of life, limit neurocognitive symptoms, and reduce accident risk.
阻塞性睡眠呼吸暂停(OSA)的诊断标准在《国际睡眠障碍分类》第三版中定义,需要通过实验室、有监督的多导睡眠图(PSG)或家庭睡眠呼吸暂停测试(HSAT)来证明呼吸事件的频率增加。然而,目前《睡眠呼吸事件的评分手册:规则、术语和技术规范》(AASM 评分手册)中有两种低通气评分标准。这种二分法导致实验室报告、患者治疗和支付方政策之间存在差异。在 OSA 测试期间,关于识别和评分“基于觉醒的呼吸事件”存在混淆。“基于觉醒的评分”在计算呼吸暂停-低通气指数(AHI)时,承认与脑电图相关的觉醒相关的低通气,无论是否有明显的氧减饱和度,或者在计算呼吸紊乱指数(RDI)时,除了低通气和呼吸暂停之外,还包括与呼吸努力相关的觉醒(RERAs)。与觉醒相关的呼吸事件,即使没有氧减饱和度,也会导致严重且潜在危险的睡眠呼吸暂停症状。在 PSG 中,对于疑似 OSA 的患者,在临床评估中应进行基于觉醒的呼吸评分,尤其是对于白天过度嗜睡、疲劳、失眠或其他神经认知症状的患者。因此,AASM 的立场是,应使用 AASM 评分手册的低通气评分标准来计算 AHI,该标准包括伴有觉醒或≥3%氧减饱和度的气流减少。如果由于支付方政策要求必须使用仅包括气流减少加≥4%氧减饱和度(并且不允许单独基于觉醒评分)的 AASM 评分手册的低通气评分标准,则也应根据 AASM 评分手册的标准对低通气进行评分。或者,AASM 评分手册包括一种报告 RDI 的选项,该选项还提供了对导致睡眠觉醒的睡眠呼吸障碍的评估。此外,鉴于大多数 HSAT 设备无法捕获觉醒,对于 HSAT 呈阴性且 OSA 风险增加的任何患者,都应进行 PSG。如果 PSG 产生的 AHI 为每小时 5 次或更多事件,或者 RDI 大于或等于每小时 5 次事件,则建议对有症状的患者进行治疗,以提高生活质量、限制神经认知症状并降低事故风险。